Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

corticosteroids

corticosteroids is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 5
Pipeline programs 11
News articles 0
Drug details — corticosteroids
Class
—
Route
—
Patents
5
Programs
11
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

corticosteroids is an FDA-listed pharmaceutical active ingredient.

Key facts

INN corticosteroids

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 2G-MSC-GVHD Phase 2 · George Institute for · Patients who have developed acute GVHD refractory to cortico
  2. IL-6 aGVHD Siltuximab: A phase II study to as... Phase 2 · Disc Medicine · Grade III/IV acute graft versus host disease of the liver of
  3. IVERMECTIN Phase 2 · George Institute for · Strongyloidiasis is caused by a parasite that is globally di
  4. Steroids switch Phase 2 · United Therapeutics Europe · Prostate Cancer
  5. corticosteroids Phase 2 · Chinese Academy of · Acute Severe Colitis (ASC)
  6. corticosteroids combined with immunoglobulin and romiplostim Phase 2 · Chinese Academy of · Primary Immune Thrombocytopenia
  7. An open-label for inteneded for treatment of - ac… Phase 1 · Anaxis Pharma · inteneded for treatment of - active rheumatoid arthritis in
  8. CB-03-01/39 Phase 1 · Cassopeia Pharmaceuticals Pvt · Test of vasocontriction properties for classification of top

Related patents

Browse patents

  1. US 11197822

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires 2041-12-09T00:00:00.000Z

    granted

  2. US 10456390

    Combinations comprising MABA compounds and corticosteroids

    Expires 2039-10-24T00:00:00.000Z

    granted

  3. US 10272037

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires 2039-04-25T00:00:00.000Z

    granted

  4. US 9782347

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires 2037-10-05T00:00:00.000Z

    granted

  5. US 8679545

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    Expires 2034-03-20T00:00:00.000Z

    granted

Frequently asked questions

What is corticosteroids?

corticosteroids is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.